🛡️ Public data only — no PHI permitted on this instance.
SC
SeekingChartis
Investment Committee Memorandum | TX | 75 beds | Grade D | EBITDA uplift $3.2M
Investment Committee Memorandum

SCENIC MOUNTAIN MEDICAL CENTER

CCN 450653 | HOWARD, TX | 75 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SCENIC MOUNTAIN MEDICAL CENTER is a 75-bed under-performing / distressed in HOWARD, TX with $43.0M in net patient revenue and a -8.5% operating margin. The hospital serves a payer mix of 23.6% Medicare, 8.9% Medicaid, and 67.5% commercial.

Thesis: Turnaround. Our ML models identify $3.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.5% to -1.2% (+736bps).

Net Revenue HCRIS$43.0M
Current EBITDA COMPUTED$-3.7M
Operating Margin COMPUTED-8.5%
Occupancy HCRIS14.4%
Revenue / Bed COMPUTED$573K
Net-to-Gross HCRIS24.0%
Distress Probability ML57.5%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
216
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -8.5% places it below the state median. Among 216 size-comparable peers (38-150 beds), the median margin is 1.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-150), prioritizing same-state peers. 216 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SCENIC MOUNTAIN MEDICAL CENTER (Target)TX75$43.0M-8.5%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
BAYLOR SW MEDICAL CENTER- WAXATX123$273.6M15.9%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
PRESBYTERIAN HOSP FLOWER MOUNDTX99$215.0M28.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$903K+210bp18mo
Cost to Collect4.5%2.5%$860K+200bp12mo
Denial Rate Reduction12.0%6.5%$852K+198bp12mo
A/R Days Reduction5200.0%3800.0%$523K+122bp9mo
Clean Claim Rate88.0%96.0%$28K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$903K
Cost to Collect
$860K
Denial Rate Reduction
$852K
A/R Days Reduction
$523K
Clean Claim Rate
$28K
Total EBITDA Uplift$3.2M
Current EBITDA$-3.7M
+ RCM Uplift+$3.2M
Pro Forma EBITDA$-509K
Current Margin-8.5%
Pro Forma Margin-1.2%
WC Released (1x)$1.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.7M$7.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.7M$6.3M0.00x-100.0%
Bull Case9.0x11.0x$-5.1M$14.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.1M$14.8M0.00x-100.0%
Bear Case11.0x10.0x$-6.2M$-6.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.2M$-9.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 14.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 216 hospitals with 38-150 beds
  • Same-state prioritization (n=217)
  • Comp margins: P25=-11.9% / P50=1.5% / P75=11.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.

Full EBITDA BridgeML AnalysisHospital ProfileStatistical ProfileDeal Screener